Literature DB >> 8934700

Predicting aggressive and socially disruptive behavior in a maximum security forensic psychiatric hospital.

C D Hill1, R Rogers, M E Bickford.   

Abstract

The predictive utility of Hare, Hart, and Cox's Psychopathy Checklist Screening Version (PCL:SV) was assessed utilizing a sample of forensic psychiatric patients from Vernon State Hospital in Vernon, Texas. A sample of 55 patients were interviewed and rated on the PCL:SV. During a six month follow up, occurrences of self-harm (suicide attempts and self mutilation), aggression (verbal abuse and threats, irritability, belligerence, and fighting) escape potential (threats and attempts), and treatment refusal (medication, tests, and physician's appointments) were rated. Separate stepwise multiple regression analyses were performed utilizing patient's age, type of charges, documented history of alcohol/drug abuse and the PCL:SV as predictor variables. Results indicate that the PCL:SV is predictive of aggression and treatment noncompliance.

Entities:  

Mesh:

Year:  1996        PMID: 8934700

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  4 in total

Review 1.  Psychopathy as a risk factor for violence.

Authors:  R D Hare
Journal:  Psychiatr Q       Date:  1999

2.  How Do Varied Populations Interact with Embodied Conversational Agents? Findings from Inner-city Adolescents and Prisoners.

Authors:  Robert C Hubal; Diana H Fishbein; Monica S Sheppard; Mallie J Paschall; Diana L Eldreth; Christopher T Hyde
Journal:  Comput Human Behav       Date:  2008-05

3.  Dimensions of psychopathy in relation to suicidal and self-injurious behavior.

Authors:  Marc T Swogger; Kenneth R Conner; Sean C Meldrum; Eric D Caine
Journal:  J Pers Disord       Date:  2009-04

4.  Predicting violent infractions in a Swiss state penitentiary: a replication study of the PCL-R in a population of sex and violent offenders.

Authors:  Jérôme Endrass; Astrid Rossegger; Frank Urbaniok; Arja Laubacher; Stefan Vetter
Journal:  BMC Psychiatry       Date:  2008-09-08       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.